Superiority of a Silk Surgical Site Wound Closure Device over Synthetic Dressings

Plast Reconstr Surg. 2024 Dec 1;154(6):1233-1244. doi: 10.1097/PRS.0000000000011316. Epub 2024 Feb 7.

Abstract

Background: Silk fibroin is an emerging biomaterial with enhanced properties of cellular regeneration, growth, and proliferation. The use of a silk fibroin wound dressing has the potential to decrease the incidence of wound-healing complications and to improve patient outcomes compared with synthetic dressing alternatives.

Methods: A randomized, single-blind clinical trial was conducted on 50 patients who were dressed with a silk fibroin dressing on 1 side of their body and 3M Steri-Strips on the contralateral side after abdominoplasty, reduction mammaplasty, or brachioplasty procedures. Data were collected over 5 postoperative visits using photographs and an investigator-administered questionnaire to monitor erythema, skin irritation, skin discomfort, need for pharmaceutical intervention, wound dehiscence, and mechanical skin injury. A comprehensive 75-patient statistical analysis was conducted, combining the results with a previously published study comparing Dermabond Prineo with the silk dressing.

Results: A total of 20.8% of patients (10 of 48) were assessed by surgeons as having skin erythema (7 to 10) on the Steri-Strip control side, with 0% (0 of 48) on the silk dressing side ( P = 0.002). The frequency of breast triple-point separation in 43 cases was 30.2% (13 of 43) on the Steri-Strip side and 9.3% (4 of 43) on the silk side ( P = 0.012). A total of 75% of patients (36 of 48) had partial or total detachment of Steri-Strips, 0% (0 of 48) had total detachment of the silk dressing, and 18.8% (9 of 48) had partial detachment of the silk dressing within the first 2 weeks ( P < 0.001).

Conclusion: A silk fibroin wound dressing significantly reduces the incidence of wound-healing complications throughout the postoperative period.

Clinical question/level of evidence: Therapeutic, II.

Clinical relevance statement: The adoption of a silk fibroin wound dressing into clinical practice has the potential to improve patient outcomes, decrease medical adhesive-related skin injuries, and reduce the rate of wound-healing complications.

Publication types

  • Randomized Controlled Trial
  • Comparative Study

MeSH terms

  • Abdominoplasty / adverse effects
  • Abdominoplasty / instrumentation
  • Abdominoplasty / methods
  • Adult
  • Aged
  • Bandages*
  • Female
  • Fibroins* / adverse effects
  • Humans
  • Male
  • Mammaplasty / adverse effects
  • Mammaplasty / methods
  • Middle Aged
  • Silk
  • Single-Blind Method
  • Surgical Wound / therapy
  • Treatment Outcome
  • Wound Closure Techniques / adverse effects
  • Wound Closure Techniques / instrumentation
  • Wound Healing*

Substances

  • Fibroins
  • Silk